Health
Health Stories
GeM enables over Rs 14.91 lakh crore procurement across 3 crore orders: Piyush Goyal – World News Network
The Government e-Marketplace (GeM) has enabled cumulative procurement of over Rs 14.91 lakh crore across three crore orders, said Union Commerce and Industry Minister Piyush Goyal while praising the success of the GeM, which completed 9 years of its launch.
Development of indigenous multi-stage Malaria vaccine ‘AdFalciVax’ is underway – World News Network
The Indian Council of Medical Research (ICMR), through its Regional Medical Research Centre, Bhubaneswar (RMRCBB) and National Institute of Malaria Research (NIMR), in partnership with the Department of Biotechnology-National Institute of Immunology (DBT-NII), is currently developing a novel recombinant chimeric malaria vaccine candidate, named AdFalciVax.
Development of indigenous multi-stage Malaria vaccine ‘AdFalciVax’ is underway – World News Network
The Indian Council of Medical Research (ICMR), through its Regional Medical Research Centre, Bhubaneswar (RMRCBB) and National Institute of Malaria Research (NIMR), in partnership with the Department of Biotechnology-National Institute of Immunology (DBT-NII), is currently developing a novel recombinant chimeric malaria vaccine candidate, named AdFalciVax.
Development of indigenous multi-stage Malaria vaccine ‘AdFalciVax’ is underway – World News Network
The Indian Council of Medical Research (ICMR), through its Regional Medical Research Centre, Bhubaneswar (RMRCBB) and National Institute of Malaria Research (NIMR), in partnership with the Department of Biotechnology-National Institute of Immunology (DBT-NII), is currently developing a novel recombinant chimeric malaria vaccine candidate, named AdFalciVax.
Development of indigenous multi-stage Malaria vaccine ‘AdFalciVax’ is underway – World News Network
The Indian Council of Medical Research (ICMR), through its Regional Medical Research Centre, Bhubaneswar (RMRCBB) and National Institute of Malaria Research (NIMR), in partnership with the Department of Biotechnology-National Institute of Immunology (DBT-NII), is currently developing a novel recombinant chimeric malaria vaccine candidate, named AdFalciVax.
Development of indigenous multi-stage Malaria vaccine ‘AdFalciVax’ is underway – World News Network
The Indian Council of Medical Research (ICMR), through its Regional Medical Research Centre, Bhubaneswar (RMRCBB) and National Institute of Malaria Research (NIMR), in partnership with the Department of Biotechnology-National Institute of Immunology (DBT-NII), is currently developing a novel recombinant chimeric malaria vaccine candidate, named AdFalciVax.